Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1
Leukemia ( IF 11.4 ) Pub Date : 2024-05-15 , DOI: 10.1038/s41375-024-02282-y Diletta Fontana , Federica Malighetti , Matteo Villa , Alfonso Zambon , Carlo Gambacorti-Passerini , Luca Mologni
中文翻译：
将培美替尼重新用作 TKI 耐药 BCR::ABL1 抑制剂
更新日期：2024-05-15
Leukemia ( IF 11.4 ) Pub Date : 2024-05-15 , DOI: 10.1038/s41375-024-02282-y Diletta Fontana , Federica Malighetti , Matteo Villa , Alfonso Zambon , Carlo Gambacorti-Passerini , Luca Mologni
|
中文翻译：
将培美替尼重新用作 TKI 耐药 BCR::ABL1 抑制剂
京公网安备 11010802027423号